- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 239/28 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 239/28
Total number of patents in this class: 344
10-year publication summary
|
39
|
36
|
31
|
26
|
19
|
26
|
14
|
19
|
15
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Syngenta Participations AG | 4970 |
15 |
| CHDI Foundation, Inc. | 104 |
11 |
| Corteva Agriscience LLC | 2494 |
11 |
| Novartis AG | 11238 |
9 |
| Bayer AG | 3045 |
8 |
| Theravance Biopharma R&D IP, LLC | 550 |
8 |
| BASF SE | 19740 |
7 |
| Boehringer Ingelheim International GmbH | 4629 |
7 |
| Incyte Corporation | 918 |
6 |
| Purdue Pharma L.P. | 519 |
6 |
| Bristol-myers Squibb Company | 5080 |
5 |
| F. Hoffmann-La Roche AG | 7958 |
5 |
| Janssen Pharmaceutica N.V. | 3839 |
5 |
| Bayer Cropscience AG | 2241 |
5 |
| Hoffmann-La Roche Inc. | 3060 |
4 |
| E. I. du Pont de Nemours and Company | 4345 |
4 |
| Takeda Pharmaceutical Company Limited | 2961 |
4 |
| Astellas Pharma Inc. | 1145 |
4 |
| Merck Sharp & Dohme LLC | 3689 |
4 |
| AstraZeneca AB | 3042 |
3 |
| Other owners | 213 |